Expansion of In Vitro Diagnostics (IVD) and Digital X-ray Diagnostic Products

「In August 2025, the company announced the development of a new model of a portable X-ray system that is easy to carry. Developed using AI technology, its patient-positioning support function assists with simple X-ray examinations in a wide range of settings, including home healthcare, mountainous areas and remote islands.」

「In the X-ray imaging diagnostics field, revenue increased mainly due to growth in sales of the Amulet Innovality digital mammography system in Latin America.」

「In the X-ray imaging diagnostics field, sales of the ultra-lightweight mobile FDR nano digital X-ray system grew, mainly in Southeast Asia, while domestic sales also performed well, resulting in higher revenue.」

「In the X-ray imaging diagnostics field, sales of the AMULET Innovality digital mammography system grew mainly in Europe, Southeast Asia and Latin America. Sales of the FDR Smart X X-ray system and FDR Go Plus mobile X-ray system also performed well, mainly in Europe, resulting in higher revenue.」

「In the X-ray imaging diagnostics field, sales of the AMULET Innovality digital mammography system remained solid, mainly in emerging markets, while sales of the CUREVISTA Open digital X-ray fluoroscopy system also increased.」

「In the CT and MRI fields, revenue increased as products from FUJIFILM Healthcare Corporation newly added to the lineup were expanded through FUJIFILM Corporation's sales channels in India and elsewhere, while demand related to COVID-19 also increased.」

「In the CT/MRI field, revenue increased due to expanded COVID-19-related demand and the expansion of cross-selling of Fuji Film Healthcare Co., Ltd.'s products through Fuji Film Co., Ltd.'s sales channels, among other factors.」

「On 31 March 2021, the acquisition of Hitachi, Ltd.'s diagnostic imaging-related business was completed, and Fuji Film Healthcare Co., Ltd., which succeeded to the business, began operations as a new Group company.」

「In December 2020, the company upgraded the NEXUS endoscopy information management system and began selling a function designed using AI technology to support the preparation of endoscopy diagnostic reports. In November 2020, it launched CAD EYE™ in Japan, an endoscopy diagnostic support function using AI technology to support the real-time detection and differentiation of lesions such as colorectal polyps.」

「In the ultrasound diagnostics field, sales of the high-end SonoSite PX ultrasound imaging diagnostic system, launched in the United States in July 2020 and Europe in August 2020, performed well.」

「In May 2020, the company launched the Muta Wako COVID-19 research reagent in Japan for the fully automated Muta Wako g1 genetic analyzer, enabling simple and rapid fully automated detection of novel coronavirus genes.」

「Demand for pneumonia testing and treatment surged due to the COVID-19 pandemic, driving growth in sales of portable ultrasound imaging diagnostic systems such as the SonoSite EdgeⅡ, which can be easily carried to patients' bedsides.」

「In December 2019, the company began selling in Japan the wireless ultrasound imaging system iViz air, which combines a palm-sized compact design with high image quality.」

「In the ultrasound diagnostics field, sales of the portable FC1-X ultrasound imaging diagnostic system, newly equipped with an automatic blood-flow measurement function for dialysis applications, increased significantly in Japan. Sales also performed well in China and emerging markets, led by the SonoSite EdgeⅡ portable ultrasound imaging diagnostic system.」

「In the X-ray imaging diagnostics field, sales of the FUJIFILM DR CALNEO Smart series of digital X-ray imaging diagnostic systems remained solid, mainly in emerging markets such as the Middle East and Africa. In Japan, sales of the portable FC1-X ultrasound imaging diagnostic system, newly equipped with an automatic blood-flow measurement function for dialysis facilities, also performed well.」

「In the X-ray imaging diagnostics field, the company began selling the portable CALNEO Xair X-ray system in October 2018. Its light, compact design and excellent portability support simple X-ray examinations and image review in space-constrained settings, including home healthcare.」

「In the endoscopy field, sales of the LASEREO series, which enables the company's proprietary special-light observation, performed well. In May 2018, the company added the 6000 system in Japan to its lineup, supporting the detection of minute lesions through image-enhancement functions.」

「In February 2018, the company launched the Fuji Dry Chem IMMUNO AG2 infectious disease testing system, which automatically determines the presence of viruses and bacteria that cause infectious diseases such as influenza and Mycoplasma pneumonia.」

「In the endoscopy field, sales of the LASEREO series, which uses two different types of laser as light sources, performed well. In May 2017, the company added the LASEREO 7000 system to its lineup, improving the brightness of observation images and supporting more detailed examination of lesions through enhanced visibility.」

「In the X-ray imaging diagnostics field, sales of the CALNEO series of DR and cassette-type digital X-ray imaging diagnostic systems, also known overseas as D-EVO, performed well. In November 2016, the company began selling the ultra-lightweight mobile digital X-ray system FUJIFILM DR CALNEO AQRO, which was made smaller and reduced to approximately one-fifth the weight of the previous model.」

「In the Medical Systems business, sales of IVD systems, a growth field, performed well, but revenue declined due to the impact of yen appreciation and other factors. In the X-ray imaging diagnostics field, sales of the CALNEO series of DR and cassette-type digital X-ray imaging diagnostic systems, also known overseas as D-EVO, remained solid. In November 2016, the company began selling the ultra-lightweight mobile digital X-ray system FUJIFILM DR CALNEO AQRO, which was made smaller and reduced to approximately one-fifth the weight of the previous model. In the IVD field, the company began selling the Fuji Dry Chem IMMUNO AG Cartridge Myco, an IVD reagent exclusively for the Fuji Dry Chem IMMUNO AG1 densitometry analyzer, which automatically determines the presence of antigens such as viruses and bacteria. The product provides simple, rapid and highly sensitive testing to support the early diagnosis of Mycoplasma pneumonia.」